News & Updates
Filter by Specialty:
COVID-19 vaccine for children below 5 years: most parents still hesitant
Widespread hesitancy around COVID-19 vaccination in children below 5 years does exist, even among parents showing preference for vaccinating their child in this age group, a US study suggests.
COVID-19 vaccine for children below 5 years: most parents still hesitant
10 Nov 2022
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
07 Nov 2022
Switch to B/F/TAF sustains virologic suppression in adult PLHIV
Adult people with HIV-1 (PLHIV) who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) after initially taking dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) or DTG+F/TAF show a consistently high virologic suppression and have few discontinuations over 5 years of follow-up, according to a study presented at the HIV Glasgow 2022 Congress.